(BLDR) Builders FirstSource - Ratings and Ratios
Lumber, Trusses, Panels, Windows, Doors, Millwork
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 45.5% |
| Value at Risk 5%th | 69.4% |
| Relative Tail Risk | -7.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.86 |
| Alpha | -51.85 |
| CAGR/Max DD | 0.31 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.396 |
| Beta | 1.088 |
| Beta Downside | 0.677 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.07% |
| Mean DD | 19.87% |
| Median DD | 17.70% |
Description: BLDR Builders FirstSource October 30, 2025
Builders FirstSource (BLDR) manufactures and distributes a broad portfolio of building-material products-including trusses, wall panels, windows, doors, millwork, siding, and lumber-as well as turn-key construction services and software tools for design, estimating, and quoting. Its customer base spans professional homebuilders, subcontractors, remodelers, and light-commercial contractors across the United States.
In FY 2023 the company reported revenue of $9.6 billion, a 7 % year-over-year increase, and an adjusted EBITDA margin of roughly 9 %, reflecting strong demand from the single-family housing market and successful cost-control initiatives. Inventory turnover accelerated to 5.2×, indicating efficient supply-chain management, while the Ready-Frame and Synboard brands now account for over 30 % of total sales, underscoring the value of its branded product lines.
Key economic drivers for BLDR include U.S. housing-starts activity (which has been rising modestly as mortgage rates stabilize), residential construction spending trends, and the availability of skilled labor. A potential headwind is a resurgence of higher interest rates, which could dampen new-home demand, while supply-chain disruptions remain a secondary risk. For a deeper quantitative view, you might explore BLDR’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (593.9m TTM) > 0 and > 6% of Revenue (6% = 939.2m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -6.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.27% (prev 9.06%; Δ 0.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 1.39b > Net Income 593.9m (YES >=105%, WARN >=100%) |
| Net Debt (356.2m) to EBITDA (1.61b) ratio: 0.22 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (110.9m) change vs 12m ago -5.14% (target <= -2.0% for YES) |
| Gross Margin 30.97% (prev 33.55%; Δ -2.58pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 140.2% (prev 153.6%; Δ -13.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.97 (EBITDA TTM 1.61b / Interest Expense TTM 259.2m) >= 6 (WARN >= 3) |
Altman Z'' 1.51
| (A) 0.13 = (Total Current Assets 3.30b - Total Current Liabilities 1.85b) / Total Assets 11.43b |
| (B) 0.01 = Retained Earnings (Balance) 122.4m / Total Assets 11.43b |
| (C) 0.09 = EBIT TTM 1.03b / Avg Total Assets 11.16b |
| (D) 0.02 = Book Value of Equity 123.5m / Total Liabilities 7.11b |
| Total Rating: 1.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.91
| 1. Piotroski 4.50pt |
| 2. FCF Yield 8.53% |
| 3. FCF Margin 6.52% |
| 4. Debt/Equity 0.15 |
| 5. Debt/Ebitda 0.22 |
| 6. ROIC - WACC (= -0.76)% |
| 7. RoE 13.84% |
| 8. Rev. Trend -69.31% |
| 9. EPS Trend -68.78% |
What is the price of BLDR shares?
Over the past week, the price has changed by -1.39%, over one month by +1.94%, over three months by -24.00% and over the past year by -36.44%.
Is BLDR a buy, sell or hold?
- Strong Buy: 11
- Buy: 5
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLDR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 134.4 | 23.9% |
| Analysts Target Price | 134.4 | 23.9% |
| ValueRay Target Price | 106 | -2.3% |
BLDR Fundamental Data Overview December 11, 2025
P/E Trailing = 19.926
P/E Forward = 18.7266
P/S = 0.7418
P/B = 2.7531
P/EG = 0.81
Beta = 1.565
Revenue TTM = 15.65b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.61b USD
Long Term Debt = 4.43b USD (from longTermDebt, last quarter)
Short Term Debt = 121.2m USD (from shortTermDebt, last quarter)
Debt = 652.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 356.2m USD (from netDebt column, last quarter)
Enterprise Value = 11.97b USD (11.61b + Debt 652.4m - CCE 296.2m)
Interest Coverage Ratio = 3.97 (Ebit TTM 1.03b / Interest Expense TTM 259.2m)
FCF Yield = 8.53% (FCF TTM 1.02b / Enterprise Value 11.97b)
FCF Margin = 6.52% (FCF TTM 1.02b / Revenue TTM 15.65b)
Net Margin = 3.79% (Net Income TTM 593.9m / Revenue TTM 15.65b)
Gross Margin = 30.97% ((Revenue TTM 15.65b - Cost of Revenue TTM 10.81b) / Revenue TTM)
Gross Margin QoQ = 30.43% (prev 30.68%)
Tobins Q-Ratio = 1.05 (Enterprise Value 11.97b / Total Assets 11.43b)
Interest Expense / Debt = 10.62% (Interest Expense 69.3m / Debt 652.4m)
Taxrate = 23.28% (37.1m / 159.5m)
NOPAT = 789.2m (EBIT 1.03b * (1 - 23.28%))
Current Ratio = 1.79 (Total Current Assets 3.30b / Total Current Liabilities 1.85b)
Debt / Equity = 0.15 (Debt 652.4m / totalStockholderEquity, last quarter 4.32b)
Debt / EBITDA = 0.22 (Net Debt 356.2m / EBITDA 1.61b)
Debt / FCF = 0.35 (Net Debt 356.2m / FCF TTM 1.02b)
Total Stockholder Equity = 4.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 593.9m / Total Assets 11.43b)
RoE = 13.84% (Net Income TTM 593.9m / Total Stockholder Equity 4.29b)
RoCE = 11.80% (EBIT 1.03b / Capital Employed (Equity 4.29b + L.T.Debt 4.43b))
RoIC = 9.16% (NOPAT 789.2m / Invested Capital 8.62b)
WACC = 9.92% (E(11.61b)/V(12.26b) * Re(10.02%) + D(652.4m)/V(12.26b) * Rd(10.62%) * (1-Tc(0.23)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.34%
[DCF Debug] Terminal Value 67.18% ; FCFE base≈1.30b ; Y1≈1.06b ; Y5≈735.5m
Fair Price DCF = 90.13 (DCF Value 9.97b / Shares Outstanding 110.6m; 5y FCF grow -22.79% → 3.0% )
EPS Correlation: -68.78 | EPS CAGR: -9.91% | SUE: 0.89 | # QB: 1
Revenue Correlation: -69.31 | Revenue CAGR: -4.23% | SUE: 0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.93 | Chg30d=-0.006 | Revisions Net=-8 | Analysts=16
EPS next Year (2026-12-31): EPS=6.46 | Chg30d=-0.022 | Revisions Net=-9 | Growth EPS=-8.3% | Growth Revenue=-0.3%
Additional Sources for BLDR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle